Company news

PYC Therapeutics Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Phylogica Strategic Update - Pivot to Platform

December 3, 2017

Quarterly Update and Appendix 4C

October 25, 2017

PYC Granted US Patent for Peptides Entering Brain Cells

October 4, 2017

New Delivery Vehicles Show Improved Performance Inside Cells

September 5, 2017

Appendix 4E - Preliminary Final Report 30 June 2017

August 31, 2017

Response to ASX Query

July 24, 2017

Operational Update June quarter

July 10, 2017

CEO and CSO Appointments

June 18, 2017

Operational Update March Quarter

April 4, 2017

Response to ASX Price Query

January 30, 2017

Genentech extends research collaboration period

December 18, 2016

NHMRC Grant Awarded to Collaborators

December 5, 2016

AGM Presentation to Shareholders

November 25, 2016

Shareholder Update

September 29, 2016

Operational Update

July 27, 2016

Chief Executive Officer Resignation

July 18, 2016

Cell-Penetrating Phylomers Improve Delivery of Drugs

June 15, 2016

R&D Tax Rebate

March 30, 2016

Phylogica Signs Agreement with MedImmune / AstraZeneca

March 30, 2016

Phylogica - New Potential For Treating Brain Injury

March 30, 2016

Phylogica Accesses Novel Half-Life Extension Technology

March 30, 2016

Technology Licence to Janssen Biotech

March 30, 2016

Share Placement raises $2.15 Million

March 30, 2016

Pfizer First Stage of Collaboration Complete

March 30, 2016

R&D tax offset refund

March 30, 2016

European Patent Granted

March 30, 2016

Core patent granted in Australia

March 30, 2016

New Patent to Discover Sophisticated Cell Penetrating Drugs

March 30, 2016

Entitlement Issue and Note Conversion

March 30, 2016

Combination therapy escalates potency of Phylogica peptides

February 11, 2016

US Patent Synthetic Phylomer Libraries

February 10, 2016

US Patent granted

February 10, 2016

Roche Collaboration Extended

February 10, 2016

Response to ASX Query - Price Query

February 10, 2016

Response to ASX price query

February 10, 2016

Response to ASX Price and Volume Query

February 10, 2016

Renounceable Issue Prospectus

February 10, 2016

Proprietary anti-cancer drug candidates

February 10, 2016

Progress on Cell Penetrating Peptides

February 10, 2016

Phylomer licenced to Le metier de Beaute

February 10, 2016

Phylomer Library Upgrade

February 10, 2016

Phylogica Patents Granted

February 10, 2016

Phylogica Limited Share Placement raises $5.2 million

February 10, 2016

Phylogica licenses peptides to UK company

February 10, 2016

Phylogica - Isogenica Technology Collaboration

February 10, 2016

Phylogica Discovery Spin-Off with University of Cambridge

February 10, 2016

Phylogica Announces Successful Collaboration with Roche

February 10, 2016

Phylogica and roche complete first stage of partnership

February 10, 2016

Pfizer Research Project Milestone

February 10, 2016

Patent Granted for Synthetic Phylomer Libraries

February 10, 2016

← Newer news releases · Older news releases →

Decks

The 5 newest of 99 decks. Every deck is listed under its year.